Paramedic Papers

Home Trauma Gelatin and HES impair clot formation ex vivo

Trauma

Gelatin and HES impair clot formation ex vivo

Gelatin 4% and hydroxyethyl starch (130/0.42) impair clot formation in a human ex vivo whole-blood resuscitation model
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine · Added 15 September 2026

Ex vivo human whole-blood model testing graded dilution with gelatin 4%, HES 130/0.42 and a balanced crystalloid — both colloids produced a clearly hypocoagulable ROTEM profile (prolonged clotting and clot formation times, reduced alpha-angle and maximum clot firmness, worst with HES) while the crystalloid alone stayed haemostatically neutral, and combining crystalloid with colloid dilution worsened the coagulopathy further.

Study type
Simulation
Design
Ex vivo human whole-blood haemodilution model
Participants
Human whole-blood samples diluted with gelatin 4%, HES 130/0.42 and balanced crystalloid (number of donors not reported)
Main finding
Gelatin and HES produced a hypocoagulable ROTEM profile (prolonged clotting and clot formation times, reduced alpha-angle and MCF), worst with HES; balanced crystalloid alone remained haemostatically neutral, and crystalloid–colloid combinations showed non-linear, ratio-dependent coagulopathy.
Caveat
Ex vivo model without transfusion or clinical outcomes; donor sample size not reported.
Bottom line
Hypothesis-generating

Why it matters in Australia (Medium relevance). ex vivo lab findings, not clinical outcome data; ACTAS carries no colloids anyway, so it confirms current crystalloid-first fluid practice (CMG 14/39) rather than changing it.

Learning goal

Weigh the coagulopathy risks of colloid choices when resuscitating major trauma patients prehospital.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Trauma